Vericel Corp (VCEL): Shareholders' Equity
$354.64M
As of 2025-12-31
$370.04M
As of 2026-06-30
+22.6%
3-year compound annual growth
+21.4%
5-year compound annual growth
+32.0%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $354.64M | +21.5% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $291.97M | +29.2% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $225.95M | +17.5% | 2026-02-26, Balance as of period end |
| 2022-12-31 | $192.27M | +12.8% | 2025-02-27, Balance as of period end |
| 2021-12-31 | $170.46M | +27.0% | 2024-02-29, Balance as of period end |
| 2020-12-31 | $134.26M | +20.9% | 2023-02-23, Balance as of period end |
| 2019-12-31 | $111.09M | +8.7% | 2022-02-24, Balance as of period end |
| 2018-12-31 | $102.23M | +353.6% | 2021-02-24, Balance as of period end |
| 2017-12-31 | $22.54M | -8.8% | 2020-02-25, Balance as of period end |
| 2016-12-31 | $24.71M | +11.6% | 2019-02-26, Balance as of period end |
| 2015-12-31 | $22.13M | -37.9% | 2018-03-05, Balance as of period end |
| 2014-12-31 | $35.64M | +815.3% | 2017-03-13, Balance as of period end |
| 2013-12-31 | $3.89M | n/m | 2016-03-14, Balance as of period end |
| 2012-12-31 | -$32.10M | n/m | 2015-03-25, Balance as of period end |
| 2011-12-31 | -$12.97M | n/m | 2014-03-13, Balance as of period end |
| 2010-12-31 | $2.92M | n/a | 2013-03-18, Balance as of period end |
| 2010-06-30 | $14.78M | -11.8% | 2013-03-18, Balance as of period end |
| 2009-06-30 | $16.75M | n/a | 2012-03-15, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Vericel Corp (VCEL) | 2025-12-31 | $354.64M | +21.5% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $218.79M | +7.9% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $698.58M | -1.7% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $87.80M | +49.0% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $472.96M | +0.1% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $1.22B | +28.9% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $381.03M | +5.6% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $11.85M | -70.0% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $102.73M | -60.4% |
Compare VCEL, ADPT, IOVA, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗